Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kristin I Brower"'
Publikováno v:
Plastic & Reconstructive Surgery.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d8fb7609ff15fd5f54249b618d52ccb5
https://doi.org/10.1097/prs.0000000000010694
https://doi.org/10.1097/prs.0000000000010694
Autor:
Benjamin A, Sarac, Anna R, Schoenbrunner, Kristin I, Brower, Girish P, Joshi, Jeffrey E, Janis
Publikováno v:
Plastic & Reconstructive Surgery. 149:733-739
Multimodal analgesia, a key component of enhanced recovery after surgery protocols, emphasizes the use of nonopioid analgesics. Preoperative and postoperative gabapentin is often included within multimodal analgesia because it has been shown to reduc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::443ab76699407e88d17ba6d78cffe7b9
https://doi.org/10.1097/prs.0000000000008836
https://doi.org/10.1097/prs.0000000000008836
Autor:
Michelle C. Nguyen, Lisa Mostafavifar, Chelsea R. Horwood, Daniel S. Eiferman, Kristin I. Brower, Eric McLaughlin, Anna Buehl, Brooke Anne Magrum
Publikováno v:
Journal of Surgical Research. 251:6-15
Background The devastating effects of the opioid epidemic are well documented. We implemented a surgeon/pharmacist opioid reduction initiative at an academic medical center that incorporated multimodal pain therapy in an attempt to reduce total inpat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a625fd2430840d0fdb91288ba486388
https://doi.org/10.1016/j.jss.2019.12.050
https://doi.org/10.1016/j.jss.2019.12.050
Publikováno v:
Hosp Pharm
Background Overuse of antibiotics from the inpatient to outpatient setting is an antibiotic stewardship initiative where noninfectious disease (ID) pharmacists can have a large impact. Our purpose was to evaluate antibiotic durations across transitio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f787138bbca8b8d16c879166202f9da
https://doi.org/10.1177/0018578720928265
https://doi.org/10.1177/0018578720928265
Publikováno v:
AA practice. 10(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::804f4895db339130c37bec0d5bfa5b2e
https://pubmed.ncbi.nlm.nih.gov/29077661
https://pubmed.ncbi.nlm.nih.gov/29077661
Autor:
Kristin I Brower, Claire Murphy, Carlos E Arias-Morales, Demicha Rankin, Marilly Palettas, Sergio D Bergese
Publikováno v:
Clinical Medicine Insights: Therapeutics, Vol 9 (2017)
Clevidipine is a third-generation dihydropyridine calcium channel blocker approved in 2008 by the Food and Drug Administration for parenteral therapy of arterial hypertension. The high degree of lipophilicity of clevidipine provides a rapid onset of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b07559ff7b6c259c3e67e27e949639f
https://doaj.org/article/17d9b7479cd14376affa0b1fc7843104
https://doaj.org/article/17d9b7479cd14376affa0b1fc7843104
Autor:
Kristin I. Brower, Claire V. Murphy
Publikováno v:
Clinical Medicine Insights: Therapeutics, Vol 2011, Iss 3, Pp 503-515 (2011)
Clinical Medicine Insights: Therapeutics, Vol 3 (2011)
Clinical Medicine Insights: Therapeutics, Vol 3 (2011)
Clevidipine is a third generation dihydropyridine calcium channel blocker recently approved by the Food and Drug Administration and is an emerging option for management of perioperative hypertension. This intravenous medication has several properties
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dd9d471dcbc34c75bd31423e0e3e630
http://la-press.com/safety-and-efficacy-of-intravenous-clevidipine-for-the-perioperative-c-a2906
http://la-press.com/safety-and-efficacy-of-intravenous-clevidipine-for-the-perioperative-c-a2906